Previous close | 1.9900 |
Open | 2.0400 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 1.9700 - 2.1850 |
52-week range | 1.1300 - 4.0400 |
Volume | |
Avg. volume | 19,514 |
Market cap | 21.405M |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1500 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.75 |
Nephros ( NASDAQ:NEPH ) Full Year 2023 Results Key Financial Results Revenue: US$14.2m (up 43% from FY 2022). Net loss...
Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Call Transcript March 7, 2024 Nephros, Inc. misses on earnings expectations. Reported EPS is $-37.91161 EPS, expectations were $-0.02. NEPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial HighlightsFourth Quarter Ended December 31, 2023 Net revenue from continuing operations was $3.3 mi